Clinical trial

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

NCT02337907

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention BI 409306 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Donepezil Normalized identity: donepezilView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-01-21

PhasePHASE2

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

PlaceboDRUG

BI 409306DRUG

DonepezilDRUG · verified · RxNorm: donepezil

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

BerlinGermany2 LublinPoland2 ParisFrance1 IndianapolisIndiana, United States1 OrlandoFlorida, United States1 RochesterNew York, United States1 CharlotteNorth Carolina, United States1 MarseilleFrance1 MontpellierFrance1 BrusselsBelgium1 ViennaAustria1 BordeauxFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02337907 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.